LMDX logo

LumiraDx Limited (LMDX)

Profile

Full Name

LumiraDx Limited

Ticker Symbol

LMDX

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United Kingdom

IPO

March 19, 2021

Indexes

Not included

Website

http://www.lumiradx.com

Employees

1210

Key Details

Price

$0.02

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$254.48M(-39.62% YoY)

Annual EPS

-$1.59(-156.45% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.02
LMDX price is $0.02

30-Day Relative Volume

7.01
LMDX 30-day relative volume is 7.01

Price Performance

Price Most recent change

-
LMDX price change on Apr 1, 2025 is unknown

Price YTD change

-
LMDX price ytd change is unknown

Price 1-year change

-
LMDX price 1-year change is unknown

Price 3-year change

-99.63%
LMDX price is down -99.63% over the past 3 years

Price Range

Price All-time high

$11.09
LMDX price is currently -99.86% below its historical high of $11.09

Price 3-year low

$0.01
LMDX price is currently +113.33% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$5.11M
LMDX market capitalization is $5.11 million

Market cap 3-year change

-99.53%
LMDX market capitalization is down -99.53% over the past 3 years

Market cap All-time high

$2.65B
LMDX market capitalization is currently -99.81% below its historical high of $2.65 billion

Market cap sector rank

13.49%
LMDX market capitalization is higher than 13.49% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
LMDX {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

+25.8%
LMDX shares outstanding is up +25.8% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.00
LMDX beta is 0.00

200-day SMA

$0.21
LMDX price is currently -92.30% below its 200-day simple moving average

50-day SMA

$0.01
LMDX price is currently +21.21% above its 50-day simple moving average

RSI

56.25
LMDX 14-day relative strength index is 56.25

Volume

7.01
LMDX 30-day relative volume is 7.01

ATR

$0.01
LMDX average true range is $0.01

10-day Historical Volatility

390.94%
LMDX 10-day historical volatility is 390.94%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$254.48M
LMDX annual revenue is $254.48 million

Revenue Analysts estimate

$89.92M
LMDX annual revenue is currently +183.00% higher than the consensus analysts' forecast

Revenue 1-year change

-39.62%
LMDX annual revenue is down -39.62% year-on-year

Revenue Sector rank

66.85%
LMDX annual revenue is higher than 66.85% of companies in Healthcare sector

EPS

EPS

-$1.59
LMDX annual earnings per share is -$1.59

EPS Analysts estimate

-$0.39
LMDX annual earnings per share is currently +307.69% higher than the consensus analysts' forecast

EPS 1-year change

-156.45%
LMDX annual earnings per share is down -156.45% year-on-year

EPS Sector rank

44.17%
LMDX annual earnings per share is higher than 44.17% of companies in Healthcare sector

Profit

Gross profit

-$35.30M
LMDX annual gross profit is -$35.30 million

Gross margin

-13.87%
LMDX annual gross profit margin is -13.87%

Operating profit

-$321.45M
LMDX annual operating income is -$321.45 million

Operating margin

-126.32%
LMDX annual operating profit margin is -126.32%

Net income

-$447.79M
LMDX annual net profit is -$447.79 million

Net margin

-176.59%
LMDX annual net profit margin is -176.59%

Expenses

Total expenses

$575.92M
LMDX annual total expenses is $575.92 million

Operating expenses

$286.14M
LMDX annual total operating expenses is $286.14 million

Cost of goods sold

$289.78M
LMDX annual cost of goods sold is $289.78 million

Selling, general & administrative expenses

$144.51M
LMDX annual SGA is $144.51 million

Depreciation and amortization

$33.29M
LMDX annual depreciation & amortization is $33.29 million

Interest expense

$134.56M
LMDX annual interest expense is $134.56 million

Income tax

$7.80M
LMDX annual income tax is $7.80 million

EBIT & EBITDA

EBIT

-$306.83M
LMDX annual earnings before interest & taxes is -$306.83 million

EBITDA

-$273.54M
LMDX annual EBITDA is -$273.54 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$441.01M
LMDX annual total assets is $441.01 million

Non current assets

$174.07M
LMDX annual long term assets is $174.07 million

Current assets

$266.94M
LMDX annual total current assets is $266.94 million

Cash and cash equivalents

$100.01M
LMDX annual cash & cash equivalents is $100.01 million

Accounts receivable

$26.68M
LMDX annual accounts receivable is $26.68 million

Inventory

$89.97M
LMDX annual inventory is $89.97 million

Liabilities

Total liabilities

$546.39M
LMDX annual total liabilities is $546.39 million

Long term liabilities

$454.59M
LMDX annual total long term liabilities is $454.59 million

Current liabilities

$91.80M
LMDX annual total current liabilities is $91.80 million

Accounts payable

$28.90M
LMDX annual accounts payable is $28.90 million

Debt

Total debt

$398.01M
LMDX annual total debt is $398.01 million

Total debt 1-year change

+19.73%
LMDX annual total debt is up +19.73% year-on-year

Long term debt

$388.78M
LMDX annual long term debt is $388.78 million

Short term debt

$9.22M
LMDX annual short term debt is $9.22 million

Equity & Capital

Shareholders equity

-$105.11M
LMDX annual stockholders equity is -$105.11 million

Book value

-$105.11M
LMDX annual book value is -$105.11 million

Retained earnings

-$1.09B
LMDX annual retained earnings is -$1.09 billion

Working capital

$175.14M
LMDX annual working capital is $175.14 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$162.11M
LMDX annual cash flow from operations is -$162.11 million

Cash from operations 1-year change

-20.45%
LMDX annual cash flow from operations is down -20.45% year-on-year

Cash from investing

-$24.98M
LMDX annual cash flow from investing activities is -$24.98 million

Cash from investing 1-year change

+76.51%
LMDX annual cash flow from investing activities is up +76.51% year-on-year

Cash from financing

$165.29M
LMDX annual cash flow from financing activities is $165.29 million

Cash from financing 1-year change

-24.53%
LMDX annual cash flow from financing activities is down -24.53% year-on-year

CAPEX

CAPEX

$24.98M
LMDX annual capital expenditures is $24.98 million

CAPEX 1-year change

-76.51%
LMDX annual capital expenditures is down -76.51% year-on-year

Free Cash Flow

Free cash flow

-$187.09M
LMDX annual free cash flow is -$187.09 million

Free cash flow 1-year change

+22.35%
LMDX annual free cash flow is up +22.35% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-13.87%
LMDX annual gross profit margin is -13.87%

Operating margin

-126.32%
LMDX annual operating profit margin is -126.32%

Net margin

-176.59%
LMDX annual net profit margin is -176.59%

ROA & ROE

ROA

-82.48%
LMDX annual return on assets is -82.48%

ROE

-1545.63%
LMDX annual return on equity is -1545.63%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
LMDX price to earnings ratio value is unknown

PE ratio Sector rank

-
LMDX price to earnings ratio is unknown

PB Ratio

PB ratio

-0.02
LMDX price to book ratio is -0.02

PB ratio Sector rank

14.32%
LMDX price to book ratio is higher than 14.32% of companies in Healthcare sector

PS Ratio

PS ratio

0.04
LMDX price to sales ratio is 0.04

PS ratio Sector rank

3.46%
LMDX price to sales ratio is higher than 3.46% of companies in Healthcare sector

Enterprise value

Enterprise value

$382.52M
LMDX enterprise value is $382.52 million

Enterprise value Sector rank

65.95%
LMDX enterprise value is higher than 65.95% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.20
LMDX EV/EBITDA is -1.20

EV/EBITDA Sector rank

40.17%
LMDX EV/EBITDA is higher than 40.17% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.91
LMDX annual current ratio is 2.91

Quick ratio

1.93
LMDX annual quick ratio is 1.93

Leverage

Debt to equity

-3.49
LMDX annual debt to equity ratio is -3.49

Interest coverage ratio

-2.28
LMDX annual interest coverage ratio is -2.28

Risk & Stability

Piotroski F-Score

2
LMDX piotroski f-score is 2

Altman Z-Score

-4.69
LMDX altman z-score is -4.69

Analyst ratings

Recent major analysts updates

Aug 28, 23 Raymond James
Outperform
May 17, 23 Raymond James
Outperform
May 17, 23 Ladenburg Thalmann
Buy
May 17, 23 Goldman Sachs
Neutral
Apr 10, 23 Raymond James
Outperform
Apr 7, 23 Raymond James
Outperform
Mar 22, 23 Raymond James
Outperform
Mar 22, 23 Goldman Sachs
Neutral
Nov 11, 22 Raymond James
Outperform
Aug 23, 22 Ladenburg Thalmann
Buy

Institutional Ownership

Similar stocks

GTBP logo
GT Biopharma (GTBP)
NSTG logo
NanoString Technologies (NSTG)
GMDA logo
Gamida Cell (GMDA)
NCNA logo
NuCana (NCNA)
LUCY logo
Innovative Eyewear (LUCY)
AEMD logo
Aethlon Medical (AEMD)
ALZN logo
Alzamend Neuro (ALZN)
Klotho Neurosciences (KLTO)
PTN logo
Palatin Technologies (PTN)
  • What is the ticker symbol for LumiraDx Limited?
  • Does LumiraDx Limited pay dividends?
  • What sector is LumiraDx Limited in?
  • What industry is LumiraDx Limited in?
  • What country is LumiraDx Limited based in?
  • When did LumiraDx Limited go public?
  • Is LumiraDx Limited in the S&P 500?
  • Is LumiraDx Limited in the NASDAQ 100?
  • Is LumiraDx Limited in the Dow Jones?
  • When was LumiraDx Limited's last earnings report?
  • When does LumiraDx Limited report earnings?
  • Should I buy LumiraDx Limited stock now?

What is the ticker symbol for LumiraDx Limited?

The ticker symbol for LumiraDx Limited is NASDAQ:LMDX

Does LumiraDx Limited pay dividends?

No, LumiraDx Limited does not pay dividends

What sector is LumiraDx Limited in?

LumiraDx Limited is in the Healthcare sector

What industry is LumiraDx Limited in?

LumiraDx Limited is in the Diagnostics & Research industry

What country is LumiraDx Limited based in?

LumiraDx Limited is headquartered in United Kingdom

When did LumiraDx Limited go public?

LumiraDx Limited's initial public offering (IPO) was on March 19, 2021

Is LumiraDx Limited in the S&P 500?

No, LumiraDx Limited is not included in the S&P 500 index

Is LumiraDx Limited in the NASDAQ 100?

No, LumiraDx Limited is not included in the NASDAQ 100 index

Is LumiraDx Limited in the Dow Jones?

No, LumiraDx Limited is not included in the Dow Jones index

When was LumiraDx Limited's last earnings report?

LumiraDx Limited's most recent earnings report was on Jan 11, 2024

When does LumiraDx Limited report earnings?

The date for LumiraDx Limited's next earnings report has not been announced yet

Should I buy LumiraDx Limited stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page